全文获取类型
收费全文 | 2130篇 |
免费 | 80篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 69篇 |
妇产科学 | 42篇 |
基础医学 | 417篇 |
口腔科学 | 17篇 |
临床医学 | 183篇 |
内科学 | 547篇 |
皮肤病学 | 17篇 |
神经病学 | 181篇 |
特种医学 | 38篇 |
外科学 | 214篇 |
综合类 | 11篇 |
预防医学 | 142篇 |
眼科学 | 5篇 |
药学 | 142篇 |
肿瘤学 | 168篇 |
出版年
2022年 | 16篇 |
2021年 | 23篇 |
2020年 | 15篇 |
2019年 | 21篇 |
2018年 | 29篇 |
2017年 | 26篇 |
2016年 | 29篇 |
2015年 | 21篇 |
2014年 | 43篇 |
2013年 | 69篇 |
2012年 | 105篇 |
2011年 | 106篇 |
2010年 | 61篇 |
2009年 | 60篇 |
2008年 | 98篇 |
2007年 | 97篇 |
2006年 | 113篇 |
2005年 | 88篇 |
2004年 | 97篇 |
2003年 | 89篇 |
2002年 | 63篇 |
2001年 | 37篇 |
2000年 | 49篇 |
1999年 | 48篇 |
1998年 | 19篇 |
1997年 | 18篇 |
1996年 | 19篇 |
1995年 | 25篇 |
1994年 | 19篇 |
1993年 | 33篇 |
1992年 | 60篇 |
1991年 | 59篇 |
1990年 | 55篇 |
1989年 | 51篇 |
1988年 | 43篇 |
1987年 | 34篇 |
1986年 | 29篇 |
1985年 | 28篇 |
1984年 | 15篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1980年 | 14篇 |
1979年 | 13篇 |
1974年 | 9篇 |
1972年 | 11篇 |
1970年 | 8篇 |
1968年 | 10篇 |
1967年 | 13篇 |
1966年 | 14篇 |
排序方式: 共有2210条查询结果,搜索用时 15 毫秒
1.
3.
Iver A. Langmoen Tryggve Lundar Ingebjørg Storm-Mathisen Sverre O. Lie Karl H. Hovind 《Child's nervous system》1991,7(1):13-15
We present 36 consecutive patients with intrinsic glioma of the pons. Tumors with exophytic expansion were excluded. There were 16 females and 20 males, ranging in age from 2 to 13 years, median 6 years. The most common presenting symptoms were cranial nerve dysfunction. unsteadiness of gait, and hemiparesis. Computed tomography (CT) showed a hypodense (17/21) or isodense (4/21) expansion of the pons. Five tumors had areas of contrast enhancement. Following information about prognosis and possible types of management, parents decided for or against radiation therapy: twentyfour children underwent irradiation and 12 did not. Median survival among children receiving a full course of irradiation was 280 days, compared to 140 days in an equivalent group of non-irradiated children. Hemiparesis presenting without cranial nerve symptoms and contrast enhancement on CT scan were poor prognostic factors, whereas sex, age, and duration of symptoms at diagnosis were unrelated to prognosis. 相似文献
4.
Fritz Heim 《Naunyn-Schmiedeberg's archives of pharmacology》1943,202(1-5):228-235
Zusammenfassung Das Protamin, Clupeinsulfat, besitzt schon in niedrigsten Konzentrationen die gleichen kolloid-osmotischen und adsorptiven Eigenschaften wie andere höhermolekulare Eiweißkörper. Bis zu 20 Clupeinsulfat verstärken die Kammertätigkeit des hypodynamen Froschherzens. Über 50 Clupeinsulfat bewirken systolischen Kammerstillstand. 0,5–5 Clupeinsulfat verstärken die Azetylcholinwirkung, größere Mengen setzen sie herab, erhöhen aber unter Umständen die Wirkungsdauer. Das Clupeinsulfat geht mit einigen höhermolekularen Eiweißkörpern Verbindungen ein, durch die diese Eiweißkörper eine Änderung in ihrer Löslichkeit, Dispersität und Adsorptionsfähigkeit erfahren.Mit 3 Textabbildungen (11 Einzelbildern). 相似文献
5.
Ohne Zusammenfassung 相似文献
6.
C Orndal N Mandahl A Rydholm M Nilbert S Heim M Akerman F Mitelman 《Acta orthopaedica Scandinavica》1990,61(2):99-105
A myxoid liposarcoma showed macroscopic, histologic, and cytogenetic heterogeneity. In one of three myxoid nodules and in the surrounding lipoma-like tumor tissue, the translocation t(12;16)(q13;p11), known to be specific for myxoid liposarcoma, was found as the sole chromosomal abnormality. In the other two nodules, additional rearrangements involving chromosomes 1, 12, and 16 were found. These aberrations were probably secondary to the primary t(12;16), and are cytogenetic evidence of clonal evolution. The complex chromosome aberrations were present in those tumor parts that had more malignant histology, indicating that the acquisition of secondary chromosomal aberrations parallels the histologic manifestations of tumor progression. 相似文献
7.
8.
9.
Elizabeth Rosyold Russell Schilder Judy Walczak S. M. DiFino P. J. Flynn T. K. Banerjee W. J. Heim Paul E. Engstrom Robert F. Ozols Peter J. O'Dwyer 《Cancer chemotherapy and pharmacology》1992,29(4):305-308
Summary Phosphonacetyl-l-aspartate (PALA), an inhibitor of aspartate transcarbamylase that depletes uridine nucleotide pools, selectively potentiates the antitumor activity of 5-fluorouracil (5-FU) in preclinical models. Due to the promising results we obtained using PALA/5-FU in colorectal cancer, we performed a phase II trial in patients presenting with advanced pancreatic cancer. PALA was given intravenously at 250 mg/m2 on day 1, followed 24 h later by 2,600 mg/m2 5-FU given by 24-h infusion. Treatments were repeated weekly. A total of 41 patients who had not previously undergone chemotherapy were entered in the trial; of these, 35 were evaluable for response. Toxicity was generally mild to moderate; neurotoxicity (13/35) and diarrhea (8/35) predominated. Among the 35 patients, 1 achieved a complete response and 4, a partial remission, for an overall response rate of 14%. The median survival was 5.1 months. Pretreatment with PALA alone was not sufficient to enhance the activity of 5-FU in pancreatic cancer.Supported in part by grant CA 06927 from the National Cancer Institute 相似文献
10.